All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

According to several attorneys general, Monday's agreements do not include Oklahoma, which in 2019 reached a $270 million settlement with Purdue Pharma and the Sacklers to resolve opioid-related ...

Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement. All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma ...

Under the outlines of the deal, members of the Sackler family who currently own Purdue Pharma are expected to contribute up to $7 billion. According to the company, a major change from past settlement ...